Sata, Masataka

Vascular Endothelial Cells and Smooth Muscle Cells Differ in Expression of Fas and Fas Ligand and in Sensitivity to Fas Ligand–Induced Cell Death: Implications for Vascular Disease and Therapy

Sata, M., Suhara, T., & Walsh, K. (2000) · Arteriosclerosis Thrombosis and Vascular Biology

Cell death mechanisms and regulationAtherosclerosis and Cardiovascular Diseases

Cited by 118

Clinical utility of single-beat E/e' obtained by simultaneous recording of flow and tissue Doppler velocities in atrial fibrillation with preserved systolic function

Kusunose, K., Yamada, H., Nishio, S., Tomita, N., Niki, T., Yamaguchi, K., Koshiba, K., Yagi, S., Taketani, Y., Iwase, T., et al. (2009) · JACC. Cardiovascular imaging

Cardiovascular Function and Risk FactorsCardiac Valve Diseases and Treatments

Cited by 88

Effects of the Addition of Eicosapentaenoic Acid to Strong Statin Therapy on Inflammatory Cytokines and Coronary Plaque Components Assessed by Integrated Backscatter Intravascular Ultrasound

Niki, T., Wakatsuki, T., Yamaguchi, K., Taketani, Y., Oeduka, H., Kusunose, K., Ise, T., Iwase, T., Yamada, H., Soeki, T., et al. (2016) · Circulation Journal

Fatty Acid Research and HealthLipoproteins and Cardiovascular Health

Cited by 83

Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation

Sahara, M., Ikutomi, M., Morita, T., Minami, Y., Nakajima, T., Hirata, Y., Nagai, R., & Sata, M. (2014) · Cardiovascular Research

Renin-Angiotensin System StudiesAtherosclerosis and Cardiovascular Diseases

Cited by 74

Dipeptidyl peptidase-4 inhibitor, linagliptin, ameliorates endothelial dysfunction and atherogenesis in normoglycemic apolipoprotein-E deficient mice

Salim, H. M., Fukuda, D., Higashikuni, Y., Tanaka, K., Hirata, Y., Yagi, S., Soeki, T., Shimabukuro, M., & Sata, M. (2016) · Vascular Pharmacology

Nitric Oxide and Endothelin EffectsDiabetes Treatment and Management

Cited by 56

α-Glucosidase inhibitor miglitol attenuates glucose fluctuation, heart rate variability and sympathetic activity in patients with type 2 diabetes and acute coronary syndrome: a multicenter randomized controlled (MACS) study

Shimabukuro, M., Tanaka, A., Sata, M., Dai, K., Shibata, Y., Inoue, Y., Ikenaga, H., Kishimoto, S., Ogasawara, K., Takashima, A., et al. (2017) · Cardiovascular Diabetology

Diabetes Treatment and ManagementDiabetes Management and Research

Cited by 38

Iron chelation and a free radical scavenger suppress angiotensin II-induced upregulation of TGF-β1 in the heart

Saito, K., Ishizaka, N., Aizawa, T., Sata, M., Iso-o, N., Noiri, E., Mori, I., Ohno, M., & Nagai, R. (2005) · American Journal of Physiology-Heart and Circulatory Physiology

Cardiac Fibrosis and RemodelingRenin-Angiotensin System Studies

Cited by 33